Mentions
1
Across all reports
Quality Score
45/ 100
Emerging player
First Seen
May 25, 2026
Indexed in atlas
Last Seen
2h ago
Most recent reference
Positioning
Synthesized from 1 mentionTempus combines genomic sequencing with AI to analyze patient data and personalize cancer treatment. It serves hospitals and biopharma companies by leveraging a large proprietary genomic database and offering clinical trial matching. Its distinctiveness lies in its integrated platform that connects molecular data with clinical outcomes to improve care.
Strengths
4 cited- Large proprietary genomic database
- AI-driven treatment personalization
- Clinical trial matching capability
- Enterprise partnerships with hospitals and biopharma
Weaknesses
4 cited- Narrow focus on oncology
- High enterprise pricing may limit adoption
- Requires integration with hospital systems
- Data privacy and regulatory challenges
Recent mentions
Showing 1 of 1- incumbent2h ago
AI-Powered Personalized Health Risk Assessment Platform
poweredpersonalizedhealthriskassessmentplatform
Validate something like Tempus
Use Tempus as a starting point and let Unycorn map adjacent opportunities, underserved segments, and feature gaps worth pursuing.